Higher afamin levels are significantly associated with the markers of obesity and the obesity-linked disorders such as metabolic syndrome, type 2 diabetes, and gestational diabetes (Figure 4) [96,97]. This evidence concerns the gene AFM and type 2 diabetes mellitus.